Metabolic control analysis of the Warburg-effect in proliferating vascular smooth muscle cells

Journal of Biomedical Science

Volumn 12, Issue 5, 2005, Pages 827-834

  Werle, Martina ^a   Jahn, Lothar ^a   Kreuzer, Jörg ^a   Höfele, Julia ^a   Elsässer, Albrecht ^a   Ackermann, Cordula ^a   Katus, Hugo A ^a   Vogt, Achim M ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Praxis für Kardiologie/Pneumologie ^*  (Germany)

Author keywords

Atherosclerosis; Metabolic control analysis; Proliferation; Vascular smooth muscle cells; Warburg effect

Indexed keywords

ENZYME; GLUCOSE; PLATELET DERIVED GROWTH FACTOR;

ANAEROBIC GLYCOLYSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL PROLIFERATION; CONTROLLED STUDY; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HUMAN CELL; METABOLIC REGULATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

CELL PROLIFERATION; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUCOSE; GLYCOLYSIS; HUMANS; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR;

EID: 27744563103     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-005-9010-5     Document Type: Article

References (39)

1. Warburg O., Über den Stoffwechsel der Tumoren. Springer, Berlin, 1926.
2. Semenza G.L., Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit. Rev. Biochem. Mol. Biol. 35: 71-103, 2000.
3. Schwickert G., Walenta S., Sundfor K., Rofstad E.K. and Mueller Klieser W., Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res. 55: 4757-4759, 1995.
4. Walenta S., Salameh A., Lyng H., Evensen J.F., Mitze M., Rofstad E.K. and Mueller Klieser W., Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am. J. Pathol. 150: 409-415, 1997.
5. Dominguez J.E., Graham J.F., Cummins C.J., Loreck D.J., Galarraga J., Van der Feen J., DeLaPaz R. and Smith B.H., Enzymes of glucose metabolism in cultured human gliomas: neoplasia is accompanied by altered hexokinase, phosphofructokinase, and glucose-6-phosphate dehydrogenase levels. Metab. Brain Dis. 2: 17-30, 1987.
6. Van Veelen C.W., Rijksen G., Van Ketel B.A. and Staal G.E., The pyruvate kinase isoenzyme shift in human gliomas: a potential marker in the treatment of gliomas. Br. J. Neurosurg. 2: 257-263, 1988.
7. Barron J.T. and Parrillo J.E., Production of lactic acid and energy metabolism in vascular smooth muscle: effect of dichloroacetate. Am. J. Physiol. 268: H713-H719, 1995.
8. Barron J.T., Kopp S.J., Tow J. and Parrillo J.E., Fatty acid, tricarboxylic acid cycle metabolites, and energy metabolism in vascular smooth muscle. Am. J. Physiol. 267: H764-H769, 1994.
9. Brand F.N., Abbott R.D. and Kannel W.B., Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study. Diabetes 38: 504-509, 1989.
10. Hall J.L., Chatham J.C., Eldar Finkelman H. and Gibbons G.H., Upregulation of glucose metabolism during intimal lesion formation is coupled to the inhibition of vascular smooth muscle cell apoptosis. Role of GSK3beta. Diabetes 50: 1171-1179, 2001.
11. Hall J.L., Matter C.M., Wang X. and Gibbons G.H., Hyperglycemia inhibits vascular smooth muscle cell apoptosis through a protein kinase C-dependent pathway. Circ. Res. 87: 574-580, 2000.
12. Hardin C.D. and Finder D.R., Glycolytic flux in permeabilized freshly isolated vascular smooth muscle cells. Am. J. Physiol. 274: C88-C96, 1998.
13. Roberts T.M., Sturek M., Dixon J.L. and Hardin C.D., Alterations in the oxidative metabolic profile in vascular smooth muscle from hyperlipidemic and diabetic swine. Mol. Cell Biochem. 217: 99-106, 2001.
14. Stamler J., Vaccaro O., Neaton J.D. and Wentworth D., Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 16: 434-444, 1993.
15. Ross J., Stagliano N., Donovan M., Breitbart R. and GS G., Atherosclerosis: a cancer of the blood vessels? Am. J. Clin. Pathol. Suppl 116: S97-S107, 2001.
16. Ross J., Cell biology of atherosclerosis. Annu. Rev. Physiol. 57: 791-804, 1995.
17. Rollins B.J., Morrison E.D., Usher P. and Flier J.S., Platelet-derived growth factor regulates glucose transporter expression. J. Biol. Chem. 263: 16523-16526, 1988.
18. Vander Heiden M.G., Plas D.R., Rathmell J.C., Fox C.J., Harris M.H. and Thompson C.B., Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol. Cell Biol. 21: 5899-5912, 2001.
19. Depre C., Vanoverschelde J.L. and Taegtmeyer H., Glucose for the heart. Circulation 99: 578-588, 1999.
20. Kubler W. and Spieckermann P.G., Regulation of glycolysis in the ischemic and the anoxic myocardium. J. Mol. Cell Cardiol. 1: 351-377, 1970.
21. BibArticle 〉 Stanley W.C., Lopaschuk G.D., Hall J.L. and McCormack J.G.1997Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventionsCardiovasc. Res.33243257
22. Stanley WC, Lopaschuk GD, Hall JL, McCormack JG (1997) Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res. 33:243-57.
23. Van Schaftingen E., Glycolysis revisited. Diabetologia 36: 581-588, 1993.
24. Kranzhofer R., Schmidt J., Pfeiffer C.A., Hagl S., Libby P. and Kubler W., Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb. Vasc. Biol. 19: 1623-1629, 1999.
25. Sodhi C.P., Phadke S.A., Batlle D. and Sahai A., Hypoxia stimulates osteopontin expression and proliferation of cultured vascular smooth muscle cells: potentiation by high glucose. Diabetes 50: 1482-1490, 2001.
26. Vogt A., Ackermann C., Noe T., Jensen D. and Kübler W., Simultaneous detection of hogh energy phsophates and metabolites of glycolysis and the Krens cycle by HPLC. Biochem. Biophys. Res. Comm. 248: 527-532, 1998.
27. Bradford M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
28. Spriet L.L., Anaerobic ATP provision, glycogenolysis and glycolysis in rat slow-twitch muscle during tetanic contractions. Pflugers Arch. 417: 278-284, 1990.
29. Thomas S. and Fell D.A., Design of metabolic control for large flux changes. J. Theor. Biol. 182: 285-298, 1996.
30. Kacser H. and Acerenza L., A universal method for achieving increases in metabolite production. Eur. J. Biochem. 216: 361-367, 1993.
31. Thomas S. and Fell D.A., The role of multiple enzyme activation in metabolic flux control. Adv. Enzyme Regul. 38: 65-85, 1995.
32. Fell D.A. and Thomas S., Physiological control of metabolic flux: the requirement for multisite modulation. Biochem. J. 311: 35-39, 1995.
33. Korzeniewski B., Harper M.E. and Brand M.D., Proportional activation coefficients during stimulation of oxidative phosphorylation by lactate and pyruvate or by vasopressin. Biochim. Biophys. Acta 1229: 315-322, 1995.
34. Fell D.A., Understanding the control of metabolism. Portland Press, London, 1997.
35. Thomas S. and Fell D.A., A control analysis exploration of the role of ATP utilisation in glycolytic-flux control and glycolytic-metabolite- concentration regulation. Eur. J. Biochem. 258: 956-967, 1998.
36. Galarraga J., Loreck D.J., Graham J.F., DeLaPaz R.L., Smith B.H., Hallgren D. and Cummins C.J., Glucose metabolism in human gliomas: correspondence of in situ and in vitro metabolic rates and altered energy metabolism. Metab. Brain Dis. 1: 279-291, 1986.
37. Weinhouse S., The Warburg hypothesis 50 years later. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 87: 115-126, 1976.
38. Schoburg D., Enzyme Handbook. Springer, Berlin, 1997.
39. Depre C., Rider M.H., Veitch K. and Hue L., Role of fructose 2,6-bisphosphate in the control of heart glycolysis. J. Biol. Chem. 268: 13274-13279, 1993.